Sustaining Physical Activity After Cancer Exercise Sessions
SPAACES
An Adaptive Physical Activity Maintenance Intervention
2 other identifiers
interventional
105
1 country
3
Brief Summary
The goal of this clinical trial is to develop and test an adaptive physical activity (PA) maintenance intervention for cancer survivors, after participating in a community-based exercise oncology program. The main questions it aims to answer are:
- Aim 1: Examine the feasibility and acceptability of the intervention among cancer survivors and community partners. The researchers will utilize quantitative surveys, focus groups, and semi-structured interviews to collect information about feasibility, implementation, adaptation, and sustainability.
- Aim 2: Examine the effects of the intervention among cancer survivors. The researchers will compare the proportion of participants achieving the exercise guidelines for cancer survivors six-months following completion of the initial exercise program. Participants will participate in a community-based exercise oncology program and then return to three months of free living. Based on the PA measured at the three-month follow-up, participants will be categorized as a "Responder" or "Incomplete Responder", and then randomized to the PA maintenance intervention. Researchers will compare those that are classified as Responders (meeting exercise guidelines for cancer survivors) and Incomplete Responders (not meeting guidelines for cancer survivors) to see what level of intervention is needed to influence sustainable behavior change in this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2024
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 4, 2024
CompletedFirst Submitted
Initial submission to the registry
March 20, 2024
CompletedFirst Posted
Study publicly available on registry
April 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedMarch 19, 2026
March 1, 2026
2.2 years
March 20, 2024
March 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Physical Activity program
Examine the number of participants achieving the exercise guidelines for cancer survivors defined as moderate-intensity aerobic training at least three times per week, for at least 30 minutes, and resistance training at least two times per week. Aerobic exercise will be measured with an accelerometer (continuous bouts of ≥5 minutes of activity at ≥3 METs) and resistance exercise will be measured with a self-report questionnaire (duration and frequency). The measures will be aggregated to determine total amount of physical activity and whether this amount meets or exceeds the recommended guidelines.
Measured at baseline, after completion of the exercise program (either 8-weeks or 12-weeks), 3-months post program, and 6-months post program
Secondary Outcomes (3)
Quality of Life (QOL)
Measured at baseline, after completion of the exercise program (either 8-weeks or 12-weeks), 3-months post program, and 6-months post program
Physical Fitness - Aerobic
Measured at baseline, after completion of the exercise program (either 8-weeks or 12-weeks), 3-months post program, and 6-months post program
Physical Fitness - muscular strength and endurance
Measured at baseline, after completion of the exercise program (either 8-weeks or 12-weeks), 3-months post program, and 6-months post program
Other Outcomes (1)
Feasibility and acceptability of the PA maintenance intervention components
Through study completion, an average of 9-months
Study Arms (4)
Group A- Complete Responder
NO INTERVENTIONParticipant is randomized to the no further intervention group.
Group B- Complete Responder
EXPERIMENTALParticipant is randomized to receive monthly physical activity behavior change discussion sessions for 3-months (total of three sessions).
Group C- Incomplete Responder
EXPERIMENTALParticipant is randomized to receive monthly physical activity behavior change discussion sessions for 3-months (total of three sessions).
Group D- Incomplete Responder
EXPERIMENTALParticipant is randomized to receive monthly physical activity behavior change discussion sessions for 3-months (total of three sessions) AND bi-weekly exercise sessions (total of six sessions).
Interventions
Monthly behavior change discussion sessions (3 total) for 12 weeks.
Monthly behavior change discussion sessions (3 total) for 12 weeks.
Monthly behavior change discussion sessions (3 total) for 12 weeks and attend bi-weekly (every other week) exercise classes that mirror the exercises completed in their respective community-based exercise program.
Eligibility Criteria
You may qualify if:
- ≥18 years old,
- Able to speak/read English,
- Diagnosed with any type of cancer,
- Completed primary or adjuvant treatment (i.e., chemotherapy, radiation therapy, surgery) within the previous five years, with no planned treatment within the next nine months. This does not include long-term or chronic therapies such as anti-hormone or targeted therapies (e.g., aromatase inhibitor, androgen deprivation therapy),
- Participant is registered/enrolled to participate in one of three community-based exercise programs.
You may not qualify if:
- Existing participation in ≥90 minutes per week of at least moderate intensity aerobic exercise AND two or more days per week of resistance exercise or known contraindications for exercise.
- Known contraindications for non-medically supervised moderate or greater intensity exercise (e.g., uncontrolled hypertension, inability to walk without an assistive device)
- Current or planned participation in another exercise oncology program (not one of the three community partner exercise programs), or previous participation in another or one of the three community partner exercise programs in the past 12-months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Colorado State Universitylead
- National Cancer Institute (NCI)collaborator
Study Sites (3)
Anschutz Medical Center
Aurora, Colorado, 80045, United States
Colorado State University
Fort Collins, Colorado, 80526, United States
University of Wyoming
Laramie, Wyoming, 82072, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 20, 2024
First Posted
April 11, 2024
Study Start
March 4, 2024
Primary Completion
May 1, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
March 19, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share